SHERLOCK 3CG™ Diamond Tip Confirmation System

TerminatedOBSERVATIONAL
Enrollment

232

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Indication for Peripheral Intravenous CatheterizationAtrial FlutterPremature Atrial ContractionPremature Ventricular ContractionPremature Junctional ContractionTachycardiaAtrioventricular BlockBundle-Branch Block
Interventions
PROCEDURE

PICC placement with SHERLOCK 3CG™ Diamond TCS with MODUS II software

The SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) is an FDA-cleared fully-integrated magnetic tracking and ECG-based PICC tip confirmation technology, indicated for use as an alternative to chest x-ray and fluoroscopy for PICC tip placement confirmation in adult patients without any alterations of cardiac rhythms that change the normal presentation of the P-wave. A software package, MODUS II, has been developed to accurately analyze the entire ECG complex and identify the correct placement of the PICC tip based on a patient's individual ECG, in the absence of an easily identifiable P-wave. This software system is designed to provide visual and/or audio cues to notify the PICC placer of the location of the PICC tip relative to the cavoatrial junction (CAJ) of the patient.

Trial Locations (8)

4575

Sunshine Coast University Hospital, Birtinya

6150

Fiona Stanley Hospital, Murdoch

26505

J.W. Ruby Memorial Hospital, Morgantown

27401

Moses Cone Hospital, Greensboro

27834

Vidant Medical Center, Greenville

44195

Cleveland Clinic, Cleveland

89144

Summerlin Hospital and Medical Center, Las Vegas

99204

Providence Sacred Heart Medical Center, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT03288766 - SHERLOCK 3CG™ Diamond Tip Confirmation System | Biotech Hunter | Biotech Hunter